This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Jul;56(7):1924-5.

doi: 10.3109/10428194.2014.987770. Epub 2015 Feb 14.

EZH2: a potential new target in T-cell lymphoma?

Lisa Giulino-Roth¹

Affiliations

PMID: 25407652
DOI: 10.3109/10428194.2014.987770

Comment

EZH2: a potential new target in T-cell lymphoma?

Lisa Giulino-Roth. Leuk Lymphoma. 2015 Jul.

. 2015 Jul;56(7):1924-5.

doi: 10.3109/10428194.2014.987770. Epub 2015 Feb 14.

Author

Lisa Giulino-Roth¹

Affiliation

¹ Division of Pediatric Hematology/Oncology, Department of Pediatrics, Weill Cornell Medical College , New York, NY , USA.

PMID: 25407652
DOI: 10.3109/10428194.2014.987770

No abstract available

PubMed Disclaimer

Comment on

Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases.
Shi M, Shahsafaei A, Liu C, Yu H, Dorfman DM. Shi M, et al. Leuk Lymphoma. 2015 Jul;56(7):2087-91. doi: 10.3109/10428194.2014.968780. Epub 2014 Oct 30. Leuk Lymphoma. 2015. PMID: 25263318

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon